The Glasgow Prognostic Score. An useful tool to predict survival in patients with advanced esophageal squamous cell carcinoma

Acta Cirúrgica Brasileira
Maria Aparecida Coelho de Arruda HenryMaria Aparecida Marchesan Rodrigues

Abstract

To evaluate the usefulness of the Glasgow Prognostic Score (GPS) in patients with esophageal carcinoma (EC). A total of 50 patients with EC were analyzed for GPS, nutritional and clinicopathologic parameters. Patients with CRP ≤ 1.0mg/L and albumin ≥ 3.5mg/L were considered as GPS = 0. Patients with only CRP increased or albumin decreased were classified as GPS = 1 and patients with CRP > 1.0mg/L and albumin < 3.5mg/L were considered as GPS = 2. GPS of 0, 1 and 2 were observed in seven, 23 and 20 patients, respectively. A significant inverse relationship was observed between GPS scores and the survival rate. The survival rate was greatest in patients with GPS = 0 and significantly higher than those from patients with GPS = 1 and GPS = 2. Minimum 12-month survival was observed in 71% patients with GPS = 0 and in 30% patients with GPS = 1. None of the patients with GPS = 2 survived for 12 months. A significant relationship between CRP or albumin individually and the survival rate was observed. No significant relationship among nutritional, clinic pathological parameters and survival was found. Glasgow Prognostic Score is an useful tool to predict survival in patients with esophageal carcinoma.

References

Jan 1, 1977·JPEN. Journal of Parenteral and Enteral Nutrition·G L BlackburnM F Smith
Feb 1, 1982·The American Journal of Clinical Nutrition·C E Cronk, A F Roche
Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H J AndreyevD Cunningham
Aug 31, 2000·Nutrition and Cancer·P O'GormanC S McArdle
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Dec 4, 2003·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·S NatsugoeUNKNOWN Kyushu Study Group for Adjuvant Therapy of Esophageal Cancer
Dec 6, 2003·The New England Journal of Medicine·Peter C Enzinger, Robert J Mayer
Jul 28, 2005·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·P Guillem, J P Triboulet
Feb 7, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Chang-Yu WangYu-Jie Huang
Mar 26, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Donald C McMillan
Nov 17, 2010·Revista do Colégio Brasileiro de Cirurgiões·Emerson Luis Gama PriscoEduardo Linhares Riello de Mello
Jan 6, 2012·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Jingeng LiuJianhua Fu

❮ Previous
Next ❯

Citations

Dec 11, 2019·Scientific Reports·Cecilia VeraarBernhard Moser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.